# A Explorative Study to Evaluate the Clinical Feasibility of AVATAMED

> **NCT04313842** · — · UNKNOWN · sponsor: **Doo-Sik Kong** · enrollment: 40 (estimated)

## Conditions studied

- Glioblastoma

## Interventions

- **DEVICE:** AVATAMED

## Key facts

- **NCT ID:** NCT04313842
- **Lead sponsor:** Doo-Sik Kong
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-07-01
- **Primary completion:** 2021-06-01
- **Final completion:** 2022-01-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2020-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04313842

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04313842, "A Explorative Study to Evaluate the Clinical Feasibility of AVATAMED". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04313842. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*